Anika Therapeutics
ANIK
#9072
Rank
HK$1.39 B
Marketcap
HK$104.17
Share price
-2.50%
Change (1 day)
40.54%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): -HK$2.03

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$2.04. In 2025 the company made an earnings per share (EPS) of -HK$5.96 an increase over its 2024 EPS that were of -HK$30.20.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$2.03-65.96%
2025-HK$5.96-80.26%
2024-HK$30.20-31.86%
2023-HK$44.32448.54%
2022-HK$8.08-455.17%
2021HK$2.27-115.68%
2020-HK$14.51-195.85%
2019HK$15.1448.46%
2018HK$10.20-40.37%
2017HK$17.10-1.8%
2016HK$17.417.77%
2015HK$16.16-21.37%
2014HK$20.5574.67%
2013HK$11.7770.45%
2012HK$6.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.40-2,669.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$32.01-1,669.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
HK$74.13-3,734.62%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.61-1,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA